SIM0718 injection

BIOLOGICAL2 trials

Sponsors

Simcere Pharmaceutical Co., Ltd

Conditions

Asthma; EosinophilicAtopic Dermatitis

Phase 3

A Study to Evaluate the Efficacy and Safety of SIM0718 in Adult and Adolescent Patients With Moderate to Severe Atopic Dermatitis

CompletedNCT06477835

Simcere Pharmaceutical Co., LtdAtopic Dermatitis

Start: 2024-07-04End: 2025-12-23Updated: 2026-03-31

SIM0718 Treatment of Asthma Clinical Study

RecruitingNCT06488755

Simcere Pharmaceutical Co., LtdAsthma; Eosinophilic

Start: 2024-06-23End: 2027-09-30Target: 418Updated: 2026-04-02